کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
3468271 1596586 2010 5 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Entecavir is an optional agent to prevent hepatitis B virus (HBV) reactivation: A review of 16 patients
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی پزشکی و دندانپزشکی (عمومی)
پیش نمایش صفحه اول مقاله
Entecavir is an optional agent to prevent hepatitis B virus (HBV) reactivation: A review of 16 patients
چکیده انگلیسی

BackgroundHepatitis B virus (HBV) reactivation is a fatal complication in patients who receive chemotherapy or immunosuppressive therapy. We examined the effect of preventive entecavir (ETV), a new nucleoside analogue on HBV reactivation during chemotherapy or immunosuppressive therapy.MethodsBetween February 2007 and September 2009, sixteen nucleoside analogue treatment-naive patients with chronic HBV infection (HB surface antigen [HBsAg] positive) who required chemotherapy or immunosuppressive therapy were enrolled. Referring to some guidelines, the patients received preventive ETV to reduce incidence of HBV reactivation, and were closely monitored for HBV markers.ResultsHBV reactivation did not occur in any of the 16 patients and the indispensable treatments for their underlying diseases could be continued. However, HBV relapsed after preventive ETV was discontinued in 2 patients.ConclusionsThis study suggests that ETV is a useful option for preventing HBV reactivation in patients with chronic HBV infection.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: European Journal of Internal Medicine - Volume 21, Issue 4, August 2010, Pages 333–337
نویسندگان
, , , , , , , , ,